Skip to main content
. Author manuscript; available in PMC: 2008 Apr 15.
Published in final edited form as: Arch Biochem Biophys. 2007 Jan 8;460(2):206–212. doi: 10.1016/j.abb.2006.12.016

Table 1.

Sequences of the LxxLL peptides identified by phage display screening of the (x)7LxxLL(x)7 library using purified hVDR in the presence of VDR agonist or antagonist. Leucine residues are highlighted in gray. Boxes indicate residues N-terminal to the LxxLL motif that display high sequence similarity. Asterisks indicate LxxLL peptides confirmed to bind mammalian hVDR in the two-hybrid assay (see Fig 1). The sequence of the known LxxLL motif in the DRIP205 protein is included for sequence comparison.

DRIP205 N graphic file with name nihms-22425-t0008.jpg graphic file with name nihms-22425-t0009.jpg graphic file with name nihms-22425-t0010.jpg L M N L L K D N
Agonist 1 D V P W Y G G L T E L L G V L E S R E
2 graphic file with name nihms-22425-t0011.jpg T graphic file with name nihms-22425-t0012.jpg M graphic file with name nihms-22425-t0013.jpg graphic file with name nihms-22425-t0014.jpg graphic file with name nihms-22425-t0015.jpg L T S L L Q N G V D H V *
3 S T L W T L L S S E G D S M *
4 Q R L W D L L D L P S P T S *
5 G S L M Q L L T E N V G T H *
6 D Q L T Q L L R S Y D A G L *
7 S M L V D L L E L Q P R Y L *
8 V S L L N L L M Q D L L D G *

Antagonist 9 D A P T S L S L Q R L L H P N M S X A
10 D A V P P P S L S D L L T R Y P E W P
11 D A P W G R S L N S L L D G Y P V S S
12 H A A E L A N L P R L L A S Y E D R L
13 L D L E G S S L N V L L R P K I D G M